Adverse Reactions of Monobenzone

Monobenzone is a depigmenting agent. It works by increasing elimination of melanin (pigment molecules) from skin cells.

Apr 7,2022  Chemical Reagents

Polyglutamic acid skin benefits

Glutamic acid is an amino acid. Polyglutamic acid is created when lots of glutamic acid molecules are linked together," says Wong. "It's produced by bacterial fermentation and is found in Nattō." [Ed

Apr 7,2022  Biochemical Engineering

Function of Coenzyme Q10

Coenzyme Q10 (CoQ10) is a substance that is naturally present in the human body, with the highest levels in the heart, liver, kidneys, and pancreas. It is sold in the United States as a dietary supple

Apr 7,2022  Biochemical Engineering

Uses and side effects of Telbivudine

Telbivudine (b-L-2u-deoxythymidine) is the unmodified b-L-enantiomer of the natural nucleoside D-thymidine. This nucleoside analog is a potent inhibitor of the replication of hepadnaviruses, including

Apr 6,2022  API

Adverse effects of Adefovir dipivoxil

Adefovir dipivoxil is a white to off-white crystalline powder with an intrinsic aqueous solubility in water of 19 mg/ml at pH 2 and 0.4 mg/ml at pH 7.2.

Apr 6,2022  API

Mechanism of action of Entecavir

Entecavir (BMS-200475) is a guanosine nucleoside analog with selective activity against hepatitis B virus (HBV), as well as some activity toward HIV. It is marketed as Baracludes, and received regulat

Apr 6,2022  API

Uses and Side effects of Elvitegravir

Elvitegravir (brand name Vitekta) is a drug used as part of antiretroviral therapy (ART). The FDA approved elvitegravir in 2012 as an antiretroviral drug (ARV) for people with HIV infection. Elvitegra

Apr 2,2022  API

Side effects of Maraviroc

Maraviroc was synthesized by Pfizer Inc as UK-427,857 (4, 4-difluoro- N-[(1S)-3-[exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[ 3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide)

Apr 2,2022  API

Side effects of Enfuvirtide

Enfuvirtide is an antiretroviral drug used in salvage regimens in (usually) highly drug-experienced individuals that suppresses replication of HIV-1 strains with multidrug resistance to reverse transc

Apr 2,2022  API

Mechanism of action of Tipranavir

Tipranavir (formerly known as PNU-140690) is the first of a new class of nonpeptide protease inhibitors, the dihydropyrone sulfonamides. Tipranavir was developed and is marketed by Boehringer Ingelhei

Apr 2,2022  API
Prev12345678910...Next>  Go to Page